AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Evaluation of Patients With Non-obstructive Coronary Arteries

Recruitingn/aAges 18 Years - anyAllStanford University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Patients with angina and non-obstructive CAD are common within clinical practice, but remain a challenge with regard to diagnosis and treatment. When these patients undergo a comprehensive evaluation at the time of invasive coronary angiography, occult coronary abnormalities are frequently found. We hope to learn the overall prevalence and presentation of these occult coronary abnormalities and its long term outcome in this patient population.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patient referred for elective coronary angiography because of a reasonable clinical suspicion of coronary ischemia. 2. Presence of angina or an anginal equivalent (including chest, back, shoulder, arm, neck, jaw discomfort, or shortness of breath brought on by physical exertion, emotional stress, or certain times of day/month). Exclusion Criteria: 1. Asymptomatic (such as a pre-op cath) 2. Status-post heart transplant 3. Age \<18 4. Renal insufficiency (creatinine \>1.5) 5. Presence of an acute coronary syndrome (STEMI or NSTEMI), Tako-tsubo, an abnormal ejection fraction (EF\<55%), cardiogenic shock, or recent VT/VF 6. Presence of another likely explanation of chest pain, such as pulmonary hypertension or aortic stenosis 7. History of adverse reaction to any of the medications being used (acetylcholine, nitroglycerin, adenosine, or heparin) 8. Currently taking vasoactive medication (such as nitroglycerin) 9. Inability to provide an informed consent, including an inability to speak, read, or understand English, Spanish, Chinese, Farsi, Japanese, Korean, Russian, or Vietnamese 10. A hearing impairment that won't allow for a typical verbal conversation or a visual impairment that won't allow for reading of the written consent 11. Participation in another study (with the exception of the Stanford Gene-PAD study) 12. A potentially vulnerable subject (including minors, pregnant women, economically and educationally disadvantaged, decisionally impaired, and homeless people)
๐Ÿ’Š

What it tests

  • 30 cc blood draw
  • Intravascular ultrasound (IVUS)
  • Coronary pressure/flow wire testing
  • Coronary pressure/flow testing: Acetycholine challenge
  • Procedure: Coronary pressure/flow testing: Nitroglycerin challenge
๐Ÿ“

Where

1 site
Stanford University School of Medicine
Stanford, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy